Drugs / human embryonic stem cell derived mesenchymal cells
human embryonic stem cell derived mesenchymal cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04232592 | Jan 2020 → Jan 2022 | adhesions of uterus | Qi Zhou | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human embryonic stem cell derived mesenchymal cells | “human embryonic stem cell derived mesenchymal cells” NCT04232592 ↗ |
| Route | Other | “intrauterine injection of human embryonic stem cell derived mesenchymal cells” NCT04232592 ↗ |